Robert Adelman
Managing Partner
United States
38 investmentsRobert Adelman is a Managing Partner based in United States. Robert Adelman has backed 38 companies, including Attralus, Aurinia Pharmaceuticals and Labrys Biologics. Investment focus areas include Health Care, Women Founded and Life Science.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (38)
| Industry | Stage | Website | |||
|---|---|---|---|---|---|
| 1 | Attralus | — | — | — | — |
| 2 | Aurinia Pharmaceuticals | — | — | — | — |
| 3 | Labrys Biologics | — | — | — | — |
| 4 | Adaptimmune | — | — | — | — |
| 5 | Metacrine | — | — | — | — |
| 6 | Seragon Pharmaceuticals | — | — | — | — |
| 7 | NorthSea Therapeutics | — | — | — | — |
| 8 | Solstice Biologics | — | — | — | — |
| 9 | Outlook Therapeutics | — | — | — | — |
| 10 | Stargazer Pharmaceuticals | — | — | — | — |
| 11 | Heart Metabolics | — | — | — | — |
| 12 | Turning Point Therapeutics | — | — | — | — |
Showing 1–12 of 38
Page 1 of 4
Access Full Contact Information
Get Robert Adelman's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
No credit card required
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.